Who is sponsoring NCT02517034?

NCT02517034 is sponsored by City of Hope Medical Center.

What drugs are being tested in NCT02517034?

Interventions in NCT02517034: Comprehensive Geriatric Assessment, Quality-of-Life Assessment, Questionnaire Administration, Survey Administration.

What condition does NCT02517034 study?

NCT02517034 studies Solid Neoplasm.

Is NCT02517034 still recruiting?

NCT02517034 is currently active, enrolled. Last updated 17 June 2025.

Last reviewed 2025-06-17 · How we verify

NCT02517034

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

Active, enrolled NA Last updated 17 June 2025

What this trial tests

NA trial testing Comprehensive Geriatric Assessment in Solid Neoplasm in 600 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

4 August 2015

Primary endpoint
28 February 2026

28 February 2026

Quick facts

Lead sponsor	City of Hope Medical Center
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	600
Start date	4 August 2015
Primary completion	28 February 2026
Estimated completion	28 February 2026
Sites	5 locations across United States

Drugs / interventions tested

Comprehensive Geriatric Assessment
Quality-of-Life Assessment
Questionnaire Administration
Survey Administration

Conditions studied

Solid Neoplasm — all drugs for Solid Neoplasm →

Sponsor

City of Hope Medical Center

Who can join

65 and older, any sex, with Solid Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized clinical trial studies a geriatric assessment intervention in predicting chemotherapy toxicity and vulnerabilities (or weakness) in older patients with cancer. Assessing patients' functional status, comorbidities, psychological state, social support, nutritional status, and cognitive function before treatment may help identify vulnerabilities, improve care, and decrease chemotherapy side effects in older patients with cancer.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.
Li D, Sun CL, Kim H, Soto-Perez-de-Celis E, et al · · 2021 · cited 328× · PMID 34591080 · DOI 10.1001/jamaoncol.2021.4158
Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study.
Magnuson A, Lemelman T, Pandya C, Goodman M, et al · · 2018 · cited 50× · PMID 28914366 · DOI 10.1007/s00520-017-3874-6
Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial.
Soto-Perez-de-Celis E, Dale W, Katheria V, Kim H, et al · · 2024 · cited 27× · PMID 38630903 · DOI 10.1002/cncr.35333
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trial.
Puts MTE, Hsu T, Mariano C, Monette J, et al · · 2019 · cited 26× · PMID 31079079 · DOI 10.1136/bmjopen-2018-024485
Geriatric assessment for the practicing clinician: The why, what, and how.
Magnuson A, Loh KP, Stauffer F, Dale W, et al · · 2024 · cited 20× · PMID 39207229 · DOI 10.3322/caac.21864
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention study.
Jayani RV, Hamparsumian A, Sun C, Li D, et al · · 2024 · cited 3× · PMID 39097801 · DOI 10.1002/cncr.35482

Verify or expand the search:

Other trials of Comprehensive Geriatric Assessment

Trials testing the same drug.

NCT07487298 — G8 Screening Tool Validation in Older Adults With Cancer in Portugal · not yet recruiting
NCT07302737 — Delirium and Heart Failure · not yet recruiting
NCT06139627 — Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherap · NA · recruiting
NCT06022965 — Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial · NA · recruiting
NCT06052826 — Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years an · Phase 2 · recruiting

Other recruiting trials for Solid Neoplasm

Currently open trials in the same condition.

NCT04147494 — Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer · EARLY_PHASE1 · active not recruiting
NCT03834961 — Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leuke · Phase 2 · active not recruiting
NCT03604315 — Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF · Phase 1 · recruiting
NCT02867592 — Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, · Phase 2 · active not recruiting
NCT02713269 — Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing · Phase 2 · active not recruiting

Other City of Hope Medical Center trials

Trials by the same sponsor.

NCT07365306 — Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant · Phase 2 · not yet recruiting
NCT07218692 — RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · Phase 2 · not yet recruiting
NCT07363408 — Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment · Phase 1 · not yet recruiting
NCT07226102 — Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic o · NA · withdrawn
NCT07225855 — Geriatric Assessment and Management for Older Adults Undergoing Chemotherapy and Radiation Therapy for Head and Neck Can · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02517034 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by City of Hope Medical Center
Last refreshed: 17 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02517034.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing